Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.
Recruiting now · Not applicable
Conditions studied: Oligospermia
In brief
Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.
Key facts
- Study ID
- NCT05842239
- Run by
- Assaf-Harofeh Medical Center
- People needed
- 15
- Starts
- 2024-01-20
- Expected to finish
- 2030-12-01
- Last updated by the study team
- 2026-04-22
Who can join
Age: 21 and older. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Age above 21 years
- At least two sperm examination showing oligospermia (<15·106 sperm/mL)
- Diagnosis of idiopathic oligospermia.
- Subject willing and able to read, understand and sign an informed consent
You may not qualify if…
- Inability to attend scheduled clinic visits and/or comply with the study protocol
- Active malignancy
- Previous treatment with chemotherapy and/or radiation therapy
- Substance use at baseline
- Severe or unstable physical disorders or major cognitive deficits at baseline
- HBOT for any reason prior to study enrolment
- Chest pathology incompatible with pressure changes (including moderate to severe asthma)
- Ear or Sinus pathology incompatible with pressure changes
- Chronic disease like diabetes mellitus, ischemic heart disease etc.
- Active smoking
Where it is running
- The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh) — Ẕerifin, Israel (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.